Huize Holding Limited to Report First Quarter 2020 Financial Results on May 29, 2020
SHENZHEN, China, May 20, 2020 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize,” or the “Company”) (NASDAQ: HUIZ), a leading independent […]
NV5 Appoints Mark Abatto as NV5 Geospatial Solutions President and Chief Operating Officer
HOLLYWOOD, Fla., May 20, 2020 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of […]
Hemlo Explorers Appoints Exploration Manager
TORONTO, May 20, 2020 (GLOBE NEWSWIRE) — Hemlo Explorers Inc. (the “Company”) (TSXV:HMLO) is pleased to announce that Mr. Dan […]
Acceleware Confirms New Test Site for RF XL Technology Pursuant to Agreements with Broadview Energy
CALGARY, Alberta, May 20, 2020 (GLOBE NEWSWIRE) — Acceleware Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leader in the […]
Enzo Biochem Launches Proprietary Test for Detection of Coronavirus SARS-CoV-2 IgG Antibody Under FDA’s Emergency Use Authorization
Second Product Offering to Expand Disease Management within Enzo’s Comprehensive COVID-19 ProgramEnzo’s ELISA Kit for SARS-CoV-2 IgG Antibody Demonstrates High […]
As COVID-19 Impacts the Consumer Wallet, Federal Programs and Lenders Provide Temporary Relief
CHICAGO, May 20, 2020 (GLOBE NEWSWIRE) — A new TransUnion (NYSE: TRU) report found that serious delinquency rates were mostly […]
GCP Applied Technologies Sends Letter to Shareholders Highlighting Strength and Commitment of Its 10 Director Nominees
CAMBRIDGE, Mass., May 20, 2020 (GLOBE NEWSWIRE) — GCP Applied Technologies Inc. (NYSE:GCP) (“GCP” or the “Company”), a leading global […]
REPEAT: AgraFlora Organics Announces Extraction Partnership with Top Tier Quebec based extractor
VANCOUVER, British Columbia, May 20, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: […]
Publication Highlights Use of Ultrafiltration for Fluid Management in COVID-19 Patients
EDEN PRAIRIE, Minn., May 20, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing […]
Fate Therapeutics Announces FDA Clearance of IND Application for FT538, First CRISPR-edited, iPSC-derived Cell Therapy
Phase 1 Clinical Study to Evaluate Multiple Doses of FT538 as Monotherapy for Acute Myeloid Leukemia and in Combination with […]
